Dr. Venigalla Rao's lab focuses on developing innovative therapies to combat HIV, particularly for vulnerable populations such as substance users. They are engineering a unique type of virus called bacteriophage T4 to deliver genetic changes to patients' own stem cells, making them resistant to HIV. This exciting approach could lead to affordable and effective treatments for HIV that work by replacing infected cells with healthy, HIV-resistant cells.